InvestorsHub Logo
Followers 26
Posts 6989
Boards Moderated 6
Alias Born 03/20/2017

Re: None

Saturday, 09/19/2020 7:08:02 PM

Saturday, September 19, 2020 7:08:02 PM

Post# of 50
Some thoughts; Altria got one director on the Lexaria board now, they will have another 2, if they continue and pay Lexaria (11 millions I think)for the rights to use the formula. This decision shall be taken within 2020 by Altria. IF they do... 11 million dollars is a lot, even for Altria. Then one can be pretty sure (?) they are commited to follow up with recent product development and a clear path to market with new products. The fact they then will have 3 directors on the board, also give them significant increasing influence. Lexaria should then; 1. get 11 million dollars, 2,license fees and 3.royalty percentage of Altrias sales. Possible FIRST catalysator, within this year. To have a new signed deal and active continued collaboration, could be a key to strengthen and close now potential further agreements within the 4-division-strategy. (Could possibly also give more credit to get Lexarias approval on Nasdaq application)

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.